Advertisement
UTMD vs VMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is UTMD is a StrongBuy and VMD is a Hold.
UTMD | VMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 82 | 22 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 19 Undervalued | 81 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 71 | |
SMR RATING 1..100 | 75 | 69 | |
PRICE GROWTH RATING 1..100 | 43 | 55 | |
P/E GROWTH RATING 1..100 | 15 | 18 | |
SEASONALITY SCORE 1..100 | 65 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UTMD's Valuation (19) in the Medical Specialties industry is somewhat better than the same rating for VMD (81) in the null industry. This means that UTMD’s stock grew somewhat faster than VMD’s over the last 12 months.
VMD's Profit vs Risk Rating (71) in the null industry is in the same range as UTMD (100) in the Medical Specialties industry. This means that VMD’s stock grew similarly to UTMD’s over the last 12 months.
VMD's SMR Rating (69) in the null industry is in the same range as UTMD (75) in the Medical Specialties industry. This means that VMD’s stock grew similarly to UTMD’s over the last 12 months.
UTMD's Price Growth Rating (43) in the Medical Specialties industry is in the same range as VMD (55) in the null industry. This means that UTMD’s stock grew similarly to VMD’s over the last 12 months.
UTMD's P/E Growth Rating (15) in the Medical Specialties industry is in the same range as VMD (18) in the null industry. This means that UTMD’s stock grew similarly to VMD’s over the last 12 months.
| UTMD | VMD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 61% | N/A |
| Stochastic ODDS (%) | 2 days ago 71% | 2 days ago 70% |
| Momentum ODDS (%) | 2 days ago 63% | 2 days ago 72% |
| MACD ODDS (%) | 2 days ago 66% | 5 days ago 76% |
| TrendWeek ODDS (%) | 2 days ago 50% | 2 days ago 77% |
| TrendMonth ODDS (%) | 2 days ago 60% | 2 days ago 78% |
| Advances ODDS (%) | 4 days ago 58% | 4 days ago 74% |
| Declines ODDS (%) | 8 days ago 51% | 2 days ago 70% |
| BollingerBands ODDS (%) | 2 days ago 57% | 2 days ago 73% |
| Aroon ODDS (%) | N/A | 2 days ago 80% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
UTMD’s FA Score shows that 2 FA rating(s) are green while VMD’s FA Score has 1 green FA rating(s).
- UTMD’s FA Score: 2 green, 3 red.
- VMD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
UTMD’s TA Score shows that 5 TA indicator(s) are bullish while VMD’s TA Score has 3 bullish TA indicator(s).
- UTMD’s TA Score: 5 bullish, 3 bearish.
- VMD’s TA Score: 3 bullish, 4 bearish.
Price Growth
UTMD (@Pharmaceuticals: Other) experienced а -0.54% price change this week, while VMD (@Medical/Nursing Services) price change was +2.95% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.16%. For the same industry, the average monthly price growth was -5.15%, and the average quarterly price growth was +14.09%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.19%. For the same industry, the average monthly price growth was -6.00%, and the average quarterly price growth was -2.76%.
Reported Earning Dates
VMD is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-2.16% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-2.19% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ORCX | 18.59 | 0.23 | +1.25% |
| Defiance Daily Target 2X Long ORCL ETF (ORCX) | |||
| TEMX | 37.92 | N/A | N/A |
| Touchstone Sands Capital Emerging Markets ex-China Growth ETF (TEMX) | |||
| DBND | 43.40 | -0.08 | -0.18% |
| DoubleLine Opportunistic Core Bond ETF (DBND) | |||
| SCHE | 36.27 | -0.18 | -0.49% |
| Schwab Emerging Markets Equity ETF (SCHE) | |||
| PJIO | 62.79 | -0.40 | -0.63% |
| PGIM Jennison Focused International Equity ETF (PJIO) | |||
UTMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with CERS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then CERS could also see price increases.
| Ticker / NAME | Correlation To UTMD | 1D Price Change % | ||
|---|---|---|---|---|
| UTMD | 100% | +0.41% | ||
| CERS - UTMD | 50% Loosely correlated | -2.52% | ||
| TMCI - UTMD | 47% Loosely correlated | -2.48% | ||
| INMD - UTMD | 47% Loosely correlated | -0.85% | ||
| ITGR - UTMD | 44% Loosely correlated | +0.06% | ||
| IART - UTMD | 43% Loosely correlated | -1.17% | ||
More | ||||
VMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, VMD has been loosely correlated with AHCO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VMD jumps, then AHCO could also see price increases.
| Ticker / NAME | Correlation To VMD | 1D Price Change % | ||
|---|---|---|---|---|
| VMD | 100% | -0.22% | ||
| AHCO - VMD | 51% Loosely correlated | +0.71% | ||
| SNN - VMD | 38% Loosely correlated | -1.41% | ||
| UTMD - VMD | 35% Loosely correlated | +0.41% | ||
| MXCT - VMD | 34% Loosely correlated | -2.68% | ||
| ATEC - VMD | 32% Poorly correlated | -4.07% | ||
More | ||||